Social Media Content Creators Driving Unofficial Trade for Unapproved Slimming Drug

An underground economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Experimental Treatment Gaining Popularity Online

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Followers are encouraged to contact these profiles directly for source information, while also obtaining discount codes.

Active Trade on Social Networks

Additionally, a robust market exists on Telegram, where communities with thousands of participants share comparison images, injection guides and claims of next-day British shipping. Sellers market the substance there before directing buyers to WhatsApp for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Healthcare Experts Voice Concerns

Nevertheless, doctors and chemists have cautions that the sale of what remains an unapproved drug in the UK is worrisome and could lead to users administering products of unknown origin.

Several professionals stated the demand for the experimental drug could be linked to the increasing price of approved slimming products such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still breach medicines, advertising, and consumer laws, potentially leading to fines, prosecution or prison.

Platform Response and Material Elimination

Based on TikTok, the platform has removed problematic material and prohibited related hashtags and query recommendations. The company stated it was dedicated to maintaining the service safe and allocating resources in strengthening enforcement strategies.

Online Marketplace Activities

Research also found groups with up to 9,000 members selling the experimental drug using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” immediately displays channels with thousands of members, populated with images of weight loss, positive reviews and detailed instructions for preparing or administering at home.

Within moments of entering one community, a vendor shared contact information, where most purchases occur. The seller sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None asked about body mass, health issues or previous experience.

Product Details and Pricing

Inside these groups, posts show black plastic packages with postal service labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20mg. When questioned how long a pen should last, vendors give contradictory answers varying between a several days to “depends on your body”.

Service Moderation and Security Measures

A representative for the messaging service stated it actively moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting materials they can’t verify. Even if the research behind retatrutide is valid, these online products may not include what they claim,” stated Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in interest to recent price rises for approved weight-loss medications such as Mounjaro. “With costs rising, patients are using online platforms. But fake treatments are extremely dangerous. You cannot know what’s contained or whether the conditions they were made in was sterile,” she said.

Her team has already encountered individuals injured by personal administration from unconfirmed sources. “We understand the disappointment, but buying from Telegram or communication platforms is taking chances with your well-being,” stated the doctor. “These materials could be contaminated or improperly measured.”

Producer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company investigational substance not yet authorized … may subject users to possibly significant health risks”.